SZSE:301408 (China)
Â
Class A
Â¥
12.16
(+0.08%)
Nov 29
Business Description
Anhui Huaren Health Pharmaceutical Co Ltd
ISIN : CNE100005YT4
Share Class Description:
SZSE:301408: Class ACompare
Compare
Traded in other countries / regions
301408.China IPO Date
2023-03-01Description
Anhui Huaren Health Pharmaceutical Co Ltd focuses on the pharmaceutical retail industry and forms a retail chain, retail centralized procurement, retail service, and retail e-commerce system.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.91 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | 6.57 | |||||
| Interest Coverage | 11.94 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.31 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.4 | |||||
| 3-Year EBITDA Growth Rate | 32.6 | |||||
| 3-Year EPS without NRI Growth Rate | 1 | |||||
| 3-Year FCF Growth Rate | -41.4 | |||||
| 3-Year Book Growth Rate | 32.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.98 | |||||
| 9-Day RSI | 45.99 | |||||
| 14-Day RSI | 48.99 | |||||
| 6-1 Month Momentum % | -1.72 | |||||
| 12-1 Month Momentum % | -31.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.55 | |||||
| Days Inventory | 102 | |||||
| Days Sales Outstanding | 42.44 | |||||
| Days Payable | 144.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.82 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| Forward Dividend Yield % | 0.82 | |||||
| 5-Year Yield-on-Cost % | 0.82 | |||||
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | -8.75 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.4 | |||||
| Operating Margin % | 4.95 | |||||
| Net Margin % | 3.07 | |||||
| FCF Margin % | 0.3 | |||||
| ROE % | 6.86 | |||||
| ROA % | 2.85 | |||||
| ROIC % | 6.65 | |||||
| ROC (Joel Greenblatt) % | 20.47 | |||||
| ROCE % | 7.41 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.74 | |||||
| PE Ratio without NRI | 34.35 | |||||
| PEG Ratio | 0.76 | |||||
| PS Ratio | 1.14 | |||||
| PB Ratio | 2.46 | |||||
| Price-to-Tangible-Book | 5.31 | |||||
| Price-to-Free-Cash-Flow | 184.23 | |||||
| Price-to-Operating-Cash-Flow | 21.46 | |||||
| EV-to-EBIT | 24.89 | |||||
| EV-to-EBITDA | 24.89 | |||||
| EV-to-Revenue | 1.13 | |||||
| EV-to-FCF | 383.5 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.8 | |||||
| Price-to-Graham-Number | 2.85 | |||||
| Earnings Yield (Greenblatt) % | 4.02 | |||||
| FCF Yield % | 0.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anhui Huaren Health Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,388.147 | ||
| EPS (TTM) (Â¥) | 0.331 | ||
| Beta | 0 | ||
| Volatility % | 38.84 | ||
| 14-Day RSI | 48.99 | ||
| 14-Day ATR (Â¥) | 0.597102 | ||
| 20-Day SMA (Â¥) | 12.613 | ||
| 12-1 Month Momentum % | -31.1 | ||
| 52-Week Range (Â¥) | 9.3 - 17.95 | ||
| Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anhui Huaren Health Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anhui Huaren Health Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anhui Huaren Health Pharmaceutical Co Ltd Frequently Asked Questions
What is Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408)'s stock price today?
The current price of SZSE:301408 is ¥12.16. The 52 week high of SZSE:301408 is ¥17.95 and 52 week low is ¥9.30.
When is next earnings date of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408)?
The next earnings date of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) is .
Does Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) pay dividends? If so, how much?
The Dividend Yield %  of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) is 0.82% (As of Today), Highest Dividend Payout Ratio of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) was 0.28. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) is 0.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers